Navigation Links
£2million project aims to revolutionize the study of cancer cells in the lab

Researchers from Queen Mary, University of London have been awarded a 2.43million grant from the European Research Council (ERC) for a project which aims to revolutionise the field of cancer cell research by using bioengineering techniques to grow the first complex 3-dimensional human 'tumour microenvironment' in the laboratory.

Even at their earliest stages, human cancers are more than just malignant cells. Other cells and chemicals that normally support and protect the body are co-opted by the malignant cancer cells to actually help them grow and spread.

Research is increasingly pointing to the importance of not just targeting the malignant cancer cells but also this wider 'tumour microenvironment' for long-term cancer treatment.

In the CANBUILD project the multi-disciplinary team of scientists will be using the latest advances in tissue engineering, biomechanics, imaging and stem cell biology which they believe will make it possible to engineer, for the first time, a complex 3-dimensional human tumour in which the different cell types of the tumour microenvironment will communicate, evolve and grow in vitro (outside the body, in the laboratory).

The CANBUILD goal is to recreate the tumour microenvironment of human high-grade serious ovarian cancer, the subtype that leads to 70 per cent of all ovarian cancer deaths, but the research may have implications for several other cancers as well.

The vision is that this project will replace inadequate techniques where human cancer cells are grown in isolation on plastic surfaces. Success in the CANBUILD project may also provide better ways of testing new drugs that target the human tumour microenvironment.

Professor Fran Balkwill, from the Barts Cancer Institute, is Principal Investigator on the CANBUILD project. Professor Balkwill said: "About half the cells in a tumour are not cancer cells, but 'healthy' cells such as immune cells and fibroblasts which the cancer is somehow corrupting to help it grow and spread.

"It seems logical that the best long-term treatments will come from combining both therapies that target the cancer cells with something aimed at the wider tumour microenvironment which, while not cancerous cells themselves, are supporting the cancer's growth.

"Growing an in vitro model which contains all these types of cells will allow us to watch how the cells communicate and how the tumour grows, teaching us more about what is going on in this complex system and hopefully giving us a model we can test new drugs on."

The five-year research plan involves:

  • 'Deconstruction' of the human ovarian cancer tumour microenvironment

  • Constructing the artificial scaffold, optimising growth of different cell types, and assembling the model

  • Comparison of the model to fresh human tissue

  • Investigating the roles of individual cells

  • Testing new treatments that target the tumour microenvironment

    The ERC funding will also allow the team to communicate their research via Centre of the Cell, Queen Mary's award-winning science education centre, online resource, widening participation and outreach project.


  • Contact: Katrina Coutts
    Queen Mary, University of London

    Related medicine news :

    1. Sickle cell project named among Top 10 Clinical Research Achievements for 2012
    2. Michigan Lake Launches Aggressive Eurasian Watermilfoil Reduction Project
    3. Do-It-Yourself Projects May Boost White-Collar Males Self-Image
    4. Austin Oral Surgery Sponsors 2013 Project Graduation for Westwood High School
    5. Obama Unveils Vast Brain-Mapping Project
    6. New projects bringing health considerations into education, energy policy, and other decisions
    7. Blue Springs Ford Dealer has Donated $7,000 so Far to Publically Nominated Charities Through the Helping Others Project
    8. Center for Emotional Restructuring Announces a Published Article Suggesting the Brain Code for Learning and Memory Prior to Human Brain and Brain Activity Map Projects
    9. Public lecture at UC Riverside to address brain-mapping project
    10. Oxblue Construction Cameras Help Two Universities Embarked on Major Building Projects Boost Stakeholder Confidence and Improve Project Management
    11. EU funds research project on obesity and metabolic complications
    Post Your Comments:
    (Date:6/27/2016)... , ... June 27, 2016 , ... ... mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... to the network of the Tennessee Counseling Association, adding exclusive benefits and promotional ...
    (Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
    (Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
    (Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
    (Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
    Breaking Medicine News(10 mins):
    (Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
    (Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
    (Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
    Breaking Medicine Technology: